Press release
MRD Testing Market Expected to Grow at 14.7% CAGR by 2030
The latest report published by VynZ Research, Global MRD Testing Market - Analysis and Forecast (2025-2030), offers a comprehensive analysis of the industry, which comprises insights on the market trends. The report also includes competitor and regional analysis, and contemporary advancements in the market.Global MRD Testing Market will at USD 3.4 Billion in 2030, and it is anticipated to grow at CAGR 14.7% during the forecast period (2025-2030)
Minimal Residual Disease (MRD) testing is a sophisticated method designed for extremely sensitive diagnostic procedures. It is extensively used for detecting tiny cancer cells that may remain in the body of the patient after surgery or treatment. The main objective of this testing is to ensure that there are no chance of a relapse.
๐๐๐ญ ๐ ๐๐ซ๐๐ ๐ฌ๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐จ๐ ๐ญ๐ก๐ข๐ฌ ๐ซ๐๐ฉ๐จ๐ซt : https://www.vynzresearch.com/healthcare/mrd-testing-market/request-sample
Different types of tests comprise MRD testing such as polymerase chain reaction (PCR), flow cytometry, and next-generation sequencing (NGS), each with varied applications. The notable trends of the market include growing incidence of cancer cases, especially blood cancers, and rising emphasis on personalized medicines and treatments. The tests allow doctors to design care plans accordingly to prevent relapse.
Rapid and significant developments in technology resulting in innovations of newer and more efficient testing methods for higher accuracy, specificity, and sensitivity is a major factor that is driving the growth of the MRD testing market. There is also a significant rise in investments in research and development to understand the implications and outcomes to ensure better patient care, which is driving adoption and market expansion.
The study is also a combination of
โข Market statistical analysis
โข Growth analysis
โข Incremental competitive analysis
โข Investment opportunity
โข Industry facts
โข Statistical figures
โข Revenue
โข Sales
โข Profits
However, the market for business strategies shares the most lucrative industry and rising product/service demand. Analysts from VynZ Research highlighted the most current trends in a market study as well.
What information does this report contain?
โข The composition of the MRD Testing Market research report is given by,
โข The study from the previous year was based on historical information from years 2018 to 2023, the current situation, trends, and ongoing market statistics in the base year of 2024, as well as an evaluation of the market opportunity for the projection period from 2025 to 2030.
โข Information on mergers and acquisitions, the rise and fall of new participants, and other trends in various populations and geographical areas. Additionally, it will be extensively covered by the market.
โข Professional evaluation of key market tendencies, technological advancements, and innovations, as well as restrictions on and difficulties with market progress.
โข Additionally, it is included in studies that employ tools like PESTEL (Political, Economic, Social, Technological, Environmental, and Legal) analysis, Porter's Five Forces Model, SWOT analysis, and other similar techniques (Strength, Weakness, Opportunity, and Threat).
๐๐๐ญ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ญ๐ข๐จ๐ง ๐ข๐ง ๐ญ๐ก๐ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐๐ฌ ๐ฉ๐๐ซ ๐ฒ๐จ๐ฎ๐ซ ๐ซ๐๐ช๐ฎ๐ข๐ซ๐๐ฆ๐๐ง๐ญ๐ฌ: https://www.vynzresearch.com/healthcare/mrd-testing-market/customize-report
Market competitive landscape-
The research study by VynZ Research presents a fair and transparent analysis of the factors influencing the leading competitors in a comprehensive company profile. It includes the following information:
โข Business Strategy
โข Company overview
โข Financial performance
โข Key Product/Service Offers
โข Performance indicators.
โข Porter's Five Forces Model.
โข Risk Analysis
โข Latest developments
โข Regional presence
โข SWOT analysis
The most prominent players in the MRD Testing Market are:-
โข Exact Sciences Corporation
โข GRAIL LLC
โข Guardant Health
โข mdxhealth.
โข Bio-Techne.QIAGEN
โข Veracyte Inc.
โข F. Hoffmann-La Roche Ltd
โข FOUNDATION MEDICINE INC.
โข Natera Inc.
Market segment analysis
The report provides thorough study data for each area based on different geographic locations, as well as reliable and precise information regarding actual sizes and amounts. The market's dominant segmentation is achieved using the following techniques:
The global market is segmented into the following sub-segments: -
Test Type Insight and Forecast 2025-2030
โข Polymerase Chain Reaction (PCR)
โข Next-Generation Sequencing (NGS)
โข Flow Cytometry
โข Others
Application Insight and Forecast 2025-2030
โข Leukemia
โข Lymphoma
โข Myeloma
โข Others
Therapy Industry Insight and Forecast 2025-2030
โข Chemotherapy
โข Immunotherapy
โข Targeted Therapy
โข Stem Cell Therapy
End User Industry Insight and Forecast 2025-2030
โข Hospitals
โข Diagnostic Laboratories
โข Academic and Research Institutions
โข Others
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐ซ๐๐ฉ๐จ๐ซ๐ญ: https://www.vynzresearch.com/buy_report/T1RZdw==/YzJsdVoyeGxYM1Z6WlhKZmJHbGpaVzV6WlE9PQ==
Forecast methodology
โข Identify the variables and their impact on market
โข Evaluate the trend of regional market
โข Evaluate the strategies of competitors
โข Identify the market dynamics including change in demand, supply, challenges and opportunities
โข Examine past market trend along with challenges analyses
โข An understanding of the framework for adoption, development, distribution, and regulation.
๐ฅ๐ฒ๐ฎ๐๐ผ๐ป๐ ๐๐ผ ๐ฃ๐๐ฟ๐ฐ๐ต๐ฎ๐๐ฒ ๐๐ต๐ถ๐ ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐:
โข Using both economic and non-economic factors, a qualitative and quantitative segmentation of the market for MRD Testing Market.
โข Identifies the region and market segment for MRD Testing Market that is predicted to grow the fastest and have the biggest market share.
โข The competitive environment, which includes recent service/product launches, joint ventures, corporate growth, and acquisitions of the companies described as well as the market share of the leading rivals.
โข In light of recent changes, how the market sees the present and the future (including growth possibilities, drivers, as well as obstacles and restraints from both developing and emerging regions).
โข Includes a thorough analysis of the market utilizing Porter's Five Forces analysis from a variety of perspectives.
๐๐ซ๐จ๐ฐ๐ฌ๐ ๐ ๐ฎ๐ฅ๐ฅ ๐๐๐ฉ๐จ๐ซ๐ญ:- https://www.vynzresearch.com/healthcare/mrd-testing-market
About VynZ Research
VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. VynZ has a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies.
Contact Us:
Call: +91-996-028-8381
Toll-Free (U.S. and Canada): +1-888-253-3960
Email: kundan@vynzresearch.com
Web: https://www.vynzresearch.com
Visit On Social Media: Facebook | Twitter | Linkedin
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release MRD Testing Market Expected to Grow at 14.7% CAGR by 2030 here
News-ID: 3734807 • Views: โฆ
More Releases from Vynz Research

CRISPR Gene Editing Market Trends, Size, Future Plans, Revenue and Forecast 2030
The latest report published by VynZ Research, Global CRISPR Gene Editing Market - Analysis and Forecast (2025-2030), offers a comprehensive analysis of the industry, which comprises insights on the market trends. The report also includes competitor and regional analysis, and contemporary advancements in the market.
Global CRISPR Gene Editing Market size reached USD 1.12 billion in 2023. It is expected to reach USD 16.75 billion by 2030, exhibiting aโฆ

Water Electrolyzer Market Will Generate Massive Growth to 2030
The latest report published by VynZ Research, Global Water Electrolyzer Market - Analysis and Forecast (2025-2030), offers a comprehensive analysis of the industry, which comprises insights on the market trends. The report also includes competitor and regional analysis, and contemporary advancements in the market.
Global Water Electrolyzer Market size reached USD 0.62 billion in 2023. It is expected to reach USD 58.5 billion by 2030, exhibiting a CAGR ofโฆ

Submarine Power Cable Market Size Rapidly Increasing Globally by 2030
The latest report published by VynZ Research, Global Submarine Power Cable Market - Analysis and Forecast (2025-2030), offers a comprehensive analysis of the industry, which comprises insights on the market trends. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The specialized transmission lines designed to carry electricity across water bodies that include rivers, lakes and seas are known submarine power cables. They enable offshoreโฆ

Aromatherapy Market Market Demand and Growth Forecast (2025-2030)
The latest report published by VynZ Research, Global Aromatherapy Market - Analysis and Forecast (2025-2030), offers a comprehensive analysis of the industry, which comprises insights on the market trends. The report also includes competitor and regional analysis, and contemporary advancements in the market.
Global Aromatherapy Market size reached USD 2.3 billion in 2023 & exhibiting a CAGR of 10.1% during 2025-2030.
The aromatherapy market has been growing steadily that isโฆ
More Releases for MRD
Minimal Residual Disease (MRD) Testing Market Booming with Hemato-Oncology Focus โฆ
Minimal Residual Disease (MRD) Testing Market Snapshot
The Minimal Residual Disease (MRD) Testing Market is projected to grow from USD 2.58 billion in 2025 to USD 5.64 billion by 2032, at a CAGR of 11.8% during the forecast period.
Coherent Market Insights proudly presents its latest Minimal Residual Disease (MRD) Testing Market Research Report, delivering a detailed examination of the U.S. Minimal Residual Disease (MRD) Testing Market outlook from 2025 to 2032.โฆ
Lucintel Forecasts the Global MRD Testing Market to Reach $3.4 billion by 2031
According to a market report by Lucintel, the future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing market is expected to reach an estimated $3.4 billion by 2031 from $1.6 billion in 2024, at a CAGR of 11.7% from 2025 to 2031. The major drivers for this market are increasingโฆ
Lucintel Forecasts the Global MRD Testing Market to Reach $3.4 billion by 2031
According to a market report by Lucintel, the future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing market is expected to reach an estimated $3.4 billion by 2031 from $1.6 billion in 2024, at a CAGR of 11.7% from 2025 to 2031.
According to a market report by Lucintel, the futureโฆ
Global MRD Testing Market Set to Reach USD 3.72 Billion by 2030
โค Global Minimal Residual Disease (MRD) Testing Market to Reach USD 3.72 Billion by 2030, Driven by Technological Advancements and Rising Cancer Incidence
The global Minimal Residual Disease (MRD) Testing Market is projected to expand from USD 1.60 billion in 2023 to USD 3.72 billion by 2030, registering a robust Compound Annual Growth Rate (CAGR) of 12.8% during the forecast period.
โค Competitive Landscape and Regional Demand
The MRD testing marketโฆ
MRD Testingย Market Projected To Witness Substantial Growth, 2024-2031
The Latest research report on the MRD Testing Market 2024 provides a comprehensive analysis of the current market landscape, with forecasts extending to 2031. This study combines qualitative and quantitative insights to highlight significant market developments, challenges, competitive dynamics, and potential opportunities and trends shaping the MRD Testing Market. The report covers market size, recent trends, growth projections, market share, and development status. Additionally, it examines government policies,โฆ
Liqomics Launches LymphoVista: Breakthrough in Minimal Residual Disease (MRD) Mo โฆ
Image: https://www.getnews.info/uploads/47d7fad53008388024cd78873530f9ca.png
Liqomics is proud to announce the launch of LymphoVista
LymphoVista (https://liqomics.com/detect-lymphoma-lymphovista/) is an advanced ctDNA-based assay specifically designed for minimal residual disease (MRD) monitoring and genotyping in lymphoma patients. LymphoVista leverages high-sensitivity circulating tumor DNA (ctDNA) detection, setting a new standard in MRD testing across lymphomas including Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Central Nervous System (CNS) Lymphomas and Follicular Lymphoma.
Revolutionizing MRD Testing in Hodgkin Lymphoma and Other Lymphomas
LymphoVistaโฆ